Molecular Oncology

Aims & Scope

Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research.

The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients.

Submissions that meet the high standards of the journal are sent for rigorous, single-blind peer review by experts in the field.

Topics include, but are not limited to: Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.

Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.

Biomarkers: diagnosis, prognosis, stratification and efficacy.

Cancer genetics, epigenetics, and genomic instability.

Minimal residual disease, pre-malignant lesions.

Cancer micro-environment.

Molecular pathology.

Tumour immunology.

Translational research.

Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).

Chemotherapy, radiotherapy and surgery.

Clinical pharmacology.

Clinical trials, integration of basic science into cancer clinical trials.

Molecular epidemiology.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,910.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Emerging functions of the <scp>EGFR</scp> in cancer

  Citation: 1191

  Authors: Sara, Daniele, Letizia

• Deconstructing the molecular portraits of breast cancer

  Citation: 1027

  Authors: Aleix, Charles M.

• MicroRNA and cancer

  Citation: 898

  Authors: Martin D., Anders H.

• The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

  Citation: 867

  Authors: Paraic A., Genee Y., Connie A., Richard M., Jeremy R., Paul T., Katrin, Eva H., Mary Helen, Ole W., Joe W., Mina J.

• The role of histone deacetylases (HDACs) in human cancer

  Citation: 806

  Authors: Santiago, Manel

• Cancer biomarkers

  Citation: 722

  Authors: N. Lynn, Daniel F.

• Targeting immunogenic cell death in cancer

  Citation: 713

  Authors: Asma, Stephen W.G.

• The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

  Citation: 696

  Authors: Thomas

• Imaging and cancer: A review

  Citation: 659

  Authors: Leonard

• Epithelial–mesenchymal transition in tumor metastasis

  Citation: 534

  Authors: Kay T., Jing